Characteristics of the 23 patients who completed the study protocol
| Age (years) | Sex | Asthma duration | Atopy | FEV1(% pred) | ΔFEV1(%) | Therapy |
|---|---|---|---|---|---|---|
| 21 | F | 1 year | ++ | 2.95 (95) | 18 | FP |
| 31 | F | >10 years | ++ | 1.69 (52) | 24 | FP |
| 42 | F | 1 year | — | 2.02 (82) | 16 | FP |
| 28 | F | >10 years | ++ | 1.94 (60) | 50 | FP |
| 19 | M | >10 years | +++ | 2.56 (54) | 80 | FP |
| 25 | M | 1 year | ++ | 4.86 (108) | 12 | FP |
| 27 | M | >10 years | ++ | 1.88 (46) | 62 | FP |
| 23 | F | 6–10 years | +++ | 2.55 (85) | 18 | FP |
| 23 | M | >10 years | +++ | 2.49 (56) | 44 | FP |
| 28 | M | 1 year | — | 4.11 (95) | 19 | FP |
| 45 | M | >10 years | ++++ | 2.05 (95) | 71 | FP |
| 21 | M | >10 years | ++ | 3.41 (79) | 22 | P |
| 33 | M | >10 years | ++ | 1.88 (49) | 26 | P |
| 24 | F | >10 years | +++ | 2.22 (72) | 33 | P |
| 24 | M | >10 years | — | 3.65 (84) | 7 | P |
| 40 | M | >10 years | +++ | 1.98 (50) | 76 | P |
| 36 | M | >10 years | +++ | 1.77 (40) | 64 | P |
| 36 | F | 1–5 years | ++ | 2.84 (88) | 13 | P |
| 28 | M | >10 years | ++ | 2.67 (59) | 30 | P |
| 22 | M | 1 year | — | 3.94 (94) | 8 | P |
| 34 | M | 1 year | ++++ | 3.25 (74) | 11 | P |
| 35 | M | 1 year | — | 4.26 (100) | 5 | P |
| 20 | M | >10 years | ++++ | 2.64 (66) | 27 | P |
FP = fluticasone propionate; P = placebo.